Cargando…
Time to and Predictors of CD4+ T-Lymphocytes Recovery in HIV-Infected Children Initiating Highly Active Antiretroviral Therapy in Ghana
Background. CD4+ T-lymphocyte monitoring is not routinely available in most resource-limited settings. We investigated predictors of time to CD4+ T-lymphocyte recovery in HIV-infected children on highly active antiretroviral (HAART) at Korle-Bu Teaching Hospital, Ghana. Methods. Time to CD4+ T-lymph...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3124224/ https://www.ncbi.nlm.nih.gov/pubmed/21738861 http://dx.doi.org/10.1155/2011/896040 |
_version_ | 1782207062975971328 |
---|---|
author | Renner, Lorna Prin, Meghan Li, Fang-Yong Goka, Bamenla Northrup, Veronika Paintsil, Elijah |
author_facet | Renner, Lorna Prin, Meghan Li, Fang-Yong Goka, Bamenla Northrup, Veronika Paintsil, Elijah |
author_sort | Renner, Lorna |
collection | PubMed |
description | Background. CD4+ T-lymphocyte monitoring is not routinely available in most resource-limited settings. We investigated predictors of time to CD4+ T-lymphocyte recovery in HIV-infected children on highly active antiretroviral (HAART) at Korle-Bu Teaching Hospital, Ghana. Methods. Time to CD4+ T-lymphocyte recovery was defined as achieving percent CD4+ T-lymphocytes of 25%. We used Cox proportional hazard models for identifying significant predictor variables. Results. Of the 233 children with complete CD4+ T-lymphocyte data, the mean age at HAART initiation was 5.5 (SD = 3.1) years. The median recovery time was 60 weeks (95% CL: 55–65). Evidence at baseline of severe suppression in CD4+ T-lymphocyte count adjusted for age, age at HAART initiation, gender, and having parents alive were statistically significant in predicting time to CD4+ T-lymphocyte recovery. Conclusions. A targeted approach based on predictors of CD4+ T-lymphocyte recovery can be a viable and cost-effective way of monitoring HAART in HIV-infected children in resource-limited settings. |
format | Online Article Text |
id | pubmed-3124224 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-31242242011-07-07 Time to and Predictors of CD4+ T-Lymphocytes Recovery in HIV-Infected Children Initiating Highly Active Antiretroviral Therapy in Ghana Renner, Lorna Prin, Meghan Li, Fang-Yong Goka, Bamenla Northrup, Veronika Paintsil, Elijah AIDS Res Treat Clinical Study Background. CD4+ T-lymphocyte monitoring is not routinely available in most resource-limited settings. We investigated predictors of time to CD4+ T-lymphocyte recovery in HIV-infected children on highly active antiretroviral (HAART) at Korle-Bu Teaching Hospital, Ghana. Methods. Time to CD4+ T-lymphocyte recovery was defined as achieving percent CD4+ T-lymphocytes of 25%. We used Cox proportional hazard models for identifying significant predictor variables. Results. Of the 233 children with complete CD4+ T-lymphocyte data, the mean age at HAART initiation was 5.5 (SD = 3.1) years. The median recovery time was 60 weeks (95% CL: 55–65). Evidence at baseline of severe suppression in CD4+ T-lymphocyte count adjusted for age, age at HAART initiation, gender, and having parents alive were statistically significant in predicting time to CD4+ T-lymphocyte recovery. Conclusions. A targeted approach based on predictors of CD4+ T-lymphocyte recovery can be a viable and cost-effective way of monitoring HAART in HIV-infected children in resource-limited settings. Hindawi Publishing Corporation 2011 2011-05-11 /pmc/articles/PMC3124224/ /pubmed/21738861 http://dx.doi.org/10.1155/2011/896040 Text en Copyright © 2011 Lorna Renner et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Study Renner, Lorna Prin, Meghan Li, Fang-Yong Goka, Bamenla Northrup, Veronika Paintsil, Elijah Time to and Predictors of CD4+ T-Lymphocytes Recovery in HIV-Infected Children Initiating Highly Active Antiretroviral Therapy in Ghana |
title | Time to and Predictors of CD4+ T-Lymphocytes Recovery in HIV-Infected Children Initiating Highly Active Antiretroviral Therapy in Ghana |
title_full | Time to and Predictors of CD4+ T-Lymphocytes Recovery in HIV-Infected Children Initiating Highly Active Antiretroviral Therapy in Ghana |
title_fullStr | Time to and Predictors of CD4+ T-Lymphocytes Recovery in HIV-Infected Children Initiating Highly Active Antiretroviral Therapy in Ghana |
title_full_unstemmed | Time to and Predictors of CD4+ T-Lymphocytes Recovery in HIV-Infected Children Initiating Highly Active Antiretroviral Therapy in Ghana |
title_short | Time to and Predictors of CD4+ T-Lymphocytes Recovery in HIV-Infected Children Initiating Highly Active Antiretroviral Therapy in Ghana |
title_sort | time to and predictors of cd4+ t-lymphocytes recovery in hiv-infected children initiating highly active antiretroviral therapy in ghana |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3124224/ https://www.ncbi.nlm.nih.gov/pubmed/21738861 http://dx.doi.org/10.1155/2011/896040 |
work_keys_str_mv | AT rennerlorna timetoandpredictorsofcd4tlymphocytesrecoveryinhivinfectedchildreninitiatinghighlyactiveantiretroviraltherapyinghana AT prinmeghan timetoandpredictorsofcd4tlymphocytesrecoveryinhivinfectedchildreninitiatinghighlyactiveantiretroviraltherapyinghana AT lifangyong timetoandpredictorsofcd4tlymphocytesrecoveryinhivinfectedchildreninitiatinghighlyactiveantiretroviraltherapyinghana AT gokabamenla timetoandpredictorsofcd4tlymphocytesrecoveryinhivinfectedchildreninitiatinghighlyactiveantiretroviraltherapyinghana AT northrupveronika timetoandpredictorsofcd4tlymphocytesrecoveryinhivinfectedchildreninitiatinghighlyactiveantiretroviraltherapyinghana AT paintsilelijah timetoandpredictorsofcd4tlymphocytesrecoveryinhivinfectedchildreninitiatinghighlyactiveantiretroviraltherapyinghana |